Axsome

Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Pharma

After trial win, Axsome eyes FDA filing for narcolepsy hopeful

The treatment, which was once a Pfizer antidepressant, reduced bouts of cataplexy and other narcolepsy symptoms in Axsome's ENCORE study.

Zoey Becker Nov 27, 2024 9:46am

Financial and business background for Stacking of money coins-stock photo Mongkol OnnuanGetty Images

Axsome to add nearly 100 Auvelity sales reps to workforce

Nov 6, 2023 12:05pm

major depressive disorder

Axsome gets depression drug Auvelity over the FDA finish line

Aug 19, 2022 10:55am

FDA

Analyst says FDA appears to be 'raising the regulatory bar'

Apr 13, 2022 10:20am